MOZECTM SEB offers controlled and targeted sirolimus drug release. Nanotech Novel Drug Delivery System features a unique formulation of Solid lipid nano spheres (SLN) consisting of sirolimus and lipid spheres. Deliverability enhanced with Mozec PTCA catheter:
Nanotech Novel Drug Delivery System for controlled release of sirolimus for ISR cases.
| Catheter Design | Rapid Exchange |
|---|---|
| Tip Entry Profile | 0.016” |
| Crossing Profile | 0.024” |
| Balloon material composition | NovalonTM |
| Balloon Compliance | Semi-compliant |
| Hydrophilic Coating | MeriGlideTM - from base of distal tip to Rx-port |
| Nominal | 7atm |
| RBP | 16atm for 2 to 4mm diameters; 14atm for 4.5mm diameter |
| Diameter/Length | 9 mm | 12 mm | 14 mm | 15 mm | 17 mm | 20 mm | 25 mm | 30 mm | 33 mm | 38 mm | 41 mm | 45 mm | 49 mm |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.00 mm | MOZS20009 | MOZS20012 | MOZS20014 | MOZS20015 | MOZS20017 | MOZS20020 | MOZS20025 | MOZS20030 | MOZS20033 | MOZS20038 | MOZS20041 | MOZS20045 | MOZS20049 |
| 2.25 mm | MOZS22509 | - | MOZS22514 | - | MOZS22517 | MOZS22520 | MOZS22525 | MOZS22530 | - | MOZS22538 | MOZS22541 | MOZS22545 | MOZS22549 |
| 2.50 mm | MOZS25009 | MOZS25014 | MOZS25017 | MOZS25020 | MOZS25025 | MOZS25030 | MOZS25038 | MOZS25041 | MOZS25045 | MOZS25049 | |||
| 2.75 mm | MOZS27509 | MOZS27514 | MOZS27517 | MOZS27520 | MOZS27525 | MOZS27530 | MOZS27538 | MOZS27541 | MOZS27545 | MOZS27549 | |||
| 3.00 mm | MOZS30009 | MOZS30014 | MOZS30017 | MOZS30020 | MOZS30025 | MOZS30030 | MOZS30038 | MOZS30041 | MOZS30045 | MOZS30049 | |||
| 3.50 mm | MOZS35009 | MOZS35014 | MOZS35017 | MOZS35020 | MOZS35025 | MOZS35030 | MOZS35038 | MOZS35041 | MOZS35045 | MOZS35049 | |||
| 4.00 mm | MOZS40009 | MOZS40014 | MOZS40017 | MOZS40020 | MOZS40025 | MOZS40030 | MOZS40038 | MOZS40041 | MOZS40045 | MOZS40049 | |||
| 4.50 mm | MOZS45009 | MOZS45014 | MOZS45017 | MOZS45020 | MOZS45025 | MOZS45030 | MOZS45038 | MOZS45041 | MOZS45045 | MOZS45049 |